Antifungal topical therapy in oral chronic candidosis. A comparative study.
The aim of the present paper was to evaluate the effect of fenticonazole and to compare it with that of ketoconazole and nystatin in the topical treatment of oral chronic candidosis. Eighty patients diagnosed with erythematous chronic candidosis were divided into four groups, according to the cream they were provided with 3% fenticonazole, 2% fenticonazole, 100000UI nystatin, and 2% ketoconazole in orabase respectively. A clinical assessment was made at 7, 15, 30 and 45 days. Fifty-one of them finished the trial. ANOVA, Kruskall Wallis and Wilcoxon tests were applied for statistical analysis. There was a significative decrease of the oral lesions in all groups (p   0.0001). The remission grade was also analysed according to the localisation: lesions in the buccal mucosa and in the comissure all the patients achieved complete resolution, whereas tongue and palate lesions showed a significative decrease in all the treatments (p   0.00001). Fenticonazole proved to be as effective as nystatin and ketoconazole in topical treatment of oral candidosis.
Lopez-De-Blanc
Silvia Adriana
SA
Catedra de Clinica Estomatologica I y II B Facultad de Odontologia. Pabellon Argentina Ciudad Universitaria, Agencia 4 (5016) Cordoba - Republica Argentina. silopez@odo.unc.edu.ar
Salati-De-Mugnolo
Nelly
N
Femopase
Fabián Libero
FL
Benitez
Mónica Beatriz
MB
Morelatto
Rosana Andrea
RA
Astrada-De-Verde
Lucía
L
Masih
Diana
D
D000287:Administration, Topical; D000704:Analysis of Variance; D000935:Antifungal Agents / Q000627:therapeutic use*; D002180:Candidiasis, Oral / Q000188:drug therapy*; D002908:Chronic Disease; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007654:Ketoconazole / Q000627:therapeutic use*; D008297:Male; D009761:Nystatin / Q000627:therapeutic use*
D000935:Antifungal Agents; D007093:Imidazoles; D009761:Nystatin; C033486:fenticonazole; D007654:Ketoconazole